SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Portola Pharmaceuticals Inc. (PTLA)

NEW YORK, Sept. 6, 2017 /PRNewswire/ -- Attorney Advertising - Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Portola Pharmaceuticals Inc. ("Portola" or the "Company") (NASDAQ: PTLA). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/ptla.

The investigation concerns whether Portola and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On September 5, 2017, after the market closed, Portola announced that the Company's oral anticoagulant Bevyxxa (betrixaban) would launch in November at the earliest, and possibly as late as the first quarter of 2018.  Having previously projected a September 2017 launch for Bevyxxa, Portola advised investors that the U.S. Food and Drug Administration would require additional time to complete review of a post-approval change to the product.  Following this news, Portola's share price has fallen as much as $3.83, or 6.44%, during intraday trading on September 6, 2017.

If you are aware of any facts relating to this investigation, or purchased Portola shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/ptla.  You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-portola-pharmaceuticals-inc-ptla-300515081.html

SOURCE Bronstein, Gewirtz & Grossman, LLC